retatrutide triple agonist 🎙️ NEW EPISODE: Retatrutide—The *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide | Triple Agonist Research
Description
If GLP-1s wipe out the good oral microbiome and the bad oral microbiome enzymes degrade GLP-1s, then people need solutions that complement GLP-1s
When does weight loss plateau happen
Each insertion introduces a small contamination risk
doi:10.1016/j.bbrc.2019.04.160 55
